Table 1. Correlation between Phospho-TCTP expression and clinicopathological characteristics in breast tumors.
| Variable | phospho-TCTP expression | p Value | |||
|---|---|---|---|---|---|
| < 1% | 1–3% | 4–9% | ≥ 10 | ||
| n(%) | n(%) | n(%) | n(%) | ||
| Age | NS(0.96) | ||||
| ≤ 49 | 2(2) | 2(2) | 18(21) | 6(7) | |
| 50–65 | 2(2) | 4(5) | 25(29) | 12(14) | |
| ≥ 66 | 1(1) | 2(2) | 7(8) | 4(5) | |
| Grade | < 0.005 | ||||
| I | 5(6) | ||||
| II | 4(5) | 19(22) | 4(5) | ||
| III | 4(5) | 31(36) | 18(21) | ||
| Lymph node | 0.032 | ||||
| Negative | 5(6) | 4(5) | 32(38) | 8(9) | |
| Positive | 4(5) | 18(21) | 14(16) | ||
| Tumor size (cm) | NS(0.16) | ||||
| ≤ 2 | 5(6) | 5(6) | 37(44) | 12(14) | |
| > 2 | 3(3) | 13(15) | 10(12) | ||
| ER+/PgR+ | 2(2) | 4(5) | 9(11) | 1(1) | 0.022 |
| ER+/PgR− | 3(4) | 3(4) | 10(12) | 4(5) | |
| ER−/PgR+ | 3(4) | 1(1) | |||
| ER−/PgR− | 1(1) | 28(33) | 16(19) | ||
| Ki-67 | 0.019 | ||||
| Negative | 5(6) | 3(4) | 12(14) | 5(6) | |
| Positive | 5(6) | 38(45) | 17(20) | ||
| HER2 | 0.021 | ||||
| Negative | 4(5) | 4(5) | 21(25) | 2(2) | |
| 2+ | 1(1) | 2(2) | 7(8) | 4(5) | |
| 3+ | 2(2) | 22(26) | 16(19) | ||
Abbreviations: ER, oestrogen receptor; PgR, progesterone receptor; NS non-significant.